BioScience Health Innovations, Inc. (BHIC) intrinsic value & 10-year financials
BioScience Health Innovations, Inc. (BHIC) has a Graham intrinsic value of $1.99 per share. At $6.78 on Oct 17, 2026, the stock trades 241% above that value. Over the last 7 fiscal years revenue grew 334.5% a year to $5.7M, with an average return on invested capital of -32298.3%.
- Graham intrinsic value
- $1.99
- Share price (Oct 17, 2026)
- $6.78
- Price vs Graham value
- 241% above
- Market cap
- $77.3M
- Revenue (FY2025)
- $5.7M
- Revenue growth (7-yr CAGR)
- 334.5%
- ROIC (10-yr avg)
- -32298.3%
- Free cash flow (FY2025)
- —
BHIC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $5.7M | $642.1K | $0.06 | — | 12.6% | 55.5% |
| FY2024 | $1.8M | $87.0K | $0.00 | — | 4.7% | 21.0% |
| FY2023 | $597.6K | -$251.5K | -$0.01 | — | -42.1% | 2100.8% |
| FY2022 | $69.3K | -$170.4K | — | — | -245.8% | 1137.3% |
| FY2021 | $0 | -$25.6K | — | — | — | -197000.0% |
| FY2020 | $0 | -$7.7K | — | — | — | -104.4% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
BioScience Health Innovations, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
BioScience Health Innovations, Inc. has historically struggled to out-earn its cost of capital, averaging just -327.6% ROIC.
BioScience Health Innovations, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, BioScience Health Innovations, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $1.99 per share.